SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-19-039589
Filing Date
2019-08-13
Accepted
2019-08-13 17:00:23
Documents
1
Group Members
ARMEN B. SHANAFELT, PH.D.LV MANAGEMENT GROUP, LLCS. EDWARD TORRESSTEVEN E. HALL, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv527492_sc13da.htm SC 13D/A 89993
  Complete submission text file 0001144204-19-039589.txt   91649
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90032 | Film No.: 191021506
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A